Traditional Chinese medicine preparation for treating bronchitis due to deficiency of both lung and spleen as well as preparation method thereof

Abstract

The invention discloses a traditional Chinese medicine preparation due to deficiency of both lung and spleen, which comprises the following bulk drugs: sargassum fusiforme, radix tinosporae, cortex lycii, sharpleaf galangal fruit, trichosanthes kirilowii Maxim, Arisaema cum Bile, ephedra stem, balloonflower root, Virginia snakeroot, flos farfarae, tingli seed, earthworm, mulberry bark, loquat leaf and fructus perillae. The invention also discloses a preparation method of the traditional Chinese medicine preparation. The traditional Chinese medicine preparation has dialectical therapy on bronchitis due to deficiency of both lung and spleen, drug effect is accurate, treatment is taken as a main method, relaxation is taken as a supplementary means, simultaneous treatment of principal and subordinate symptoms can be realized, and curative effect is obvious.

Description

technical field [0001] The invention relates to the field of traditional Chinese medicine preparations, in particular to a traditional Chinese medicine preparation for treating spleen and lung deficiency type bronchitis and a preparation method thereof. Background technique [0002] Bronchitis is an inflammatory change of the trachea and bronchial mucosa caused by infection or non-infection factors, increased mucus secretion, and the lack of negative ions reduces the activity of respiratory enzymes in the epithelial villi of the tracheal mucosa, affecting the secretion function of the alveoli and the ventilation and exchange of the lungs. Qi function, clinically characterized by long-term cough, expectoration or accompanied by wheezing. The early symptoms of the disease are relatively mild, mostly in winter, relieved after the warm spring, and the course of the disease is slow, so it is not noticed by people. When the disease progresses in the late stage and obstructive emp...

AI Technical Summary

Problems solved by technology

[0011] Although the above-mentioned western medicine treatment method can also achieve a certain therapeutic effect, excessive use of antibiotics will increase the drug resistance of the pathogenic bacteria Staphylococcus, Streptococcus, Escherichia coli, Klebsiella pneumoniae and Pseudomonas aeruginosa of bronchitis, resulting in ineffective treatment. Thorough, easy to repeat and other consequences occur, and antibiotics are not suitable for everyone, and the scope of application is limited

[0012] At present, conventional methods for treating bronchitis include Chinese patent medicines, such as Jiuhuahuayuan (Bairui Granules), Sorilao Qingfei Zhike Capsules, and Yanlixiao Capsules. The cycle is long and has certain side effects, causing a lot of trouble to patients

[0013] In the prior art, there are too many treatment options for bronchitis. For example, Chinese patent CN103330817B discloses "a traditional Chinese medicine for treating bronchitis". , perilla leaf, grass cypress branch, bamboo leaf orchid, magnolia officinalis flower, loquat leaf, Houttuynia cordata, honey barrel flower and Pinellia chinensis", compared with the formula of the present invention, only "loquat leaf" The medicine overlaps, but the components of the two are different, and the technical effects achieved are different, and the precious Chinese medicinal material "ginseng" is used in its formula, which increases the cost of medicine; another example is disclosed in Chinese patent CN103341151B. Traditional Chinese medicine for the treatment of chronic bronchitis, its formula is "white mustard seed, astragalus root, bitter almond, cinnamon twig, honeysuckle, inula, asarum, jujube, saffron, cattail, cortex, radish, mulberry leaf, Although the composition of dogwood, coix seed, citrus aurantium, tangerine peel, dried ginger and raspberry has achieved a certain therapeutic effect, it has not been treated dialectically, and the drug effect is not exact enough. Compared with the formula of the present invention, there is no overlapping drug, Does not affect the invention